We are live on ! Find out more

Micro Cap Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
PPCB icon
276
Propanc Biopharma
PPCB
$1.73M
$1.73M $1.76 6.38%
ELAB icon
277
PMGC Holdings
ELAB
$1.72M
$1.72M $1.47 0.68%
HCWB icon
278
HCW Biologics
HCWB
$1.71M
$1.71M $0.7639 1.65%
CMND icon
279
Clearmind Medicine
CMND
$1.55M
$1.55M $3.06 11.3%
GNPX icon
280
Genprex
GNPX
$1.4M
$1.4M $1.71 2.4%
NIKI icon
281
Niki BioSolutions
NIKI
$1.3M
$1.3M $1.60 6.67%
GOVX icon
282
GeoVax Labs
GOVX
$1.08M
$1.08M $1.99 1%
VBIO icon
283
Valion Bio
VBIO
$1.05M
$1.05M $0.5024 7.55%
BBLG icon
284
Bone Biologics
BBLG
$986K
$986K $0.2910 5.92%
SCNI icon
285
Scinai Immunotherapeutics
SCNI
$966K
$966K $0.3673 1.4%
APVO icon
286
Aptevo Therapeutics
APVO
$943K
$943K $0.4460 3.25%
SLXN icon
287
Silexion Therapeutics
SLXN
$935K
$935K $1.44 12.7%
ARTL icon
288
Artelo Biosciences
ARTL
$822K
$822K $1.50 10.7%
SPRC icon
289
SciSparc
SPRC
$665K
$665K $0.2701 18.1%
VRAX icon
290
Virax Biolabs
VRAX
$578K
$578K $0.4300 3.39%
DCOY icon
291
Decoy Therapeutics
DCOY
$577K
$577K $0.8800 7.31%
LABT icon
292
Lakewood-Amedex Biotherapeutics
LABT
$569K
$569K $0.2400 11.9%
BDRX icon
293
Biodexa Pharmaceuticals
BDRX
$562K
$562K $2.04 4.67%
CDT icon
294
CDT Equity
CDT
$349K
$349K $0.3430 4.72%

Micro Cap Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 294 micro cap Biotechnology stocks — companies in the Biotechnology industry with a market cap under $250M — worth a combined $17.7B.

The largest by market cap are Clinuvel Pharmaceuticals (CUVL) at $245M, Lexeo Therapeutics (LXEO) at $242M and Allogene Therapeutics (ALLO) at $241M.

Among institutional investors, Faeth Therapeutics (FTH) drew the most net new fund positions in Q3 2026: 41 funds opened new positions, taking total fund holders up 34 (76%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q3 2026.